Coya Therapeutics, COYA 302, Amyotrophic Lateral Sclerosis, ALS, ALSTARS Trial, Open-Label Extension, OLE, Phase 2/3 Clinical Trial, Regulatory T Cells, Treg,

HOUSTON, October 14, 2026 Coya Therapeutics, Inc. (NASDAQ: COYA), a clinical-stage biotechnology company developing therapies designed to enhance regulatory...